Viewing Study NCT00490568


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-03 @ 6:53 AM
Study NCT ID: NCT00490568
Status: TERMINATED
Last Update Posted: 2017-11-13
First Post: 2007-06-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Sponsor: GlaxoSmithKline
Organization: